Neag Comprehensive Cancer Center/University of Connecticut Health Center

Farmington, Connecticut 06030

0 studies enrolling now · 1 studies all time

What they study most

Urothelial Carcinoma

Studies at this site

• DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma — Stopped early